# OnCo record cll-ipi (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/cll-ipi/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "cll-ipi" ;
  schema:name "CLL-IPI (chronic lymphocytic leukaemia prognostic index)"@en ;
  schema:alternateName "CLL-IPI"@en, "CLL International Prognostic Index"@en, "CLL-IPI score"@en, "beta-2 microglobulin in CLL"@en, "B2M in CLL"@en, "very high risk CLL"@en, "high-risk CLL"@en ;
  schema:description "CLL-IPI scores five things at diagnosis (TP53 loss or mutation, unmutated IGHV, raised beta-2 microglobulin, advanced stage and age over 65) to predict time to first treatment and survival; TP53 and IGHV are the two that still change which drug is chosen, because they decide whether chemo-immunotherapy is ever an option."@en ;
  schema:url <https://onco.cc/terms/cll-ipi/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/del17p-tp53/>, <https://onco.cc/terms/ighv-status/>, <https://onco.cc/terms/staging-systems/>, <https://onco.cc/terms/fish/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/acalabrutinib/>, <https://onco.cc/drugs/zanubrutinib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/obinutuzumab/> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/cll-treatment-naive/> .